Evolutionary Genetics of Tsetse and Its Symbionts

采采蝇及其共生体的进化遗传学

基本信息

  • 批准号:
    8696158
  • 负责人:
  • 金额:
    $ 69.4万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-01-15 至 2019-01-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): African trypanosomiasis impacts both human and animal health in Sub-Saharan Africa. Uganda is the only country that has both forms of the human African trypanosomiasis (HAT): Trypanosoma brucei gambiense (Tbg) in the north-west and Trypanosoma brucei rhodesiense (Tbr) in the south-east. Tbr cases have been migrating from their traditional foci in the south to central Uganda, with the two disease belts feared to merge in northern Uganda. This interdisciplinary project focuses on northern Uganda to understand HAT transmission dynamics and risk of Tbr and Tbg disease merger. Our findings will provide fundamental knowledge on the role of the vector in HAT epidemiology, and provide practical information to inform the development and implementation of effective control strategies. We propose five integrated aims to: 1) Analyze the genomic variation in Gff, its associated microbiome and parasite (Trypanosoma) using a multispecies SNP chip, 2) Characterize the expression and genetic variations of the Trypanosoma-resistance candidate genes in different Gff population groups, 3) Discover gene-environment associations and impacts of climate change on Ugandan Gff, 4) Understand genetic as well as microbiome contributions for differentiation of Gff populations and 5) Assess the impact of Gff dispersal on the effectiveness and cost-effectiveness of vector control for reducing trypanosomiasis burden. Our studies will produce 1) fundamental information on host-parasite interactions that will predict the potential risk of disease merger and its epidemiological consequences, 2) suitability maps for Gff based on genetic and environmental data to better plan and operate vector control activities, 3) candidate genes on parasite-resistance, environmental adaptations that can be used in downstream genetic control methods and 4) predictions on the most effective and cost-effective control methods for HAT.
描述(申请人提供):非洲锥虫病影响撒哈拉以南非洲的人类和动物健康。乌干达是唯一有两种人类非洲锥虫病(HAT)的国家:西北部的布氏冈比亚锥虫(TBG)和东南部的布氏锥虫(TBR)。TBR病例一直在从乌干达南部的传统疫源地向中部迁移,乌干达北部的两个疾病带恐怕会合并。这一跨学科项目的重点是乌干达北部,以了解HAT传播动态和TBR和TBG疾病合并的风险。我们的发现将提供有关媒介在HAT流行病学中的作用的基本知识,并为制定和实施有效的控制策略提供实用信息。我们提出了五个综合目标:1)使用多物种SNP芯片分析GFF及其相关微生物群和寄生虫(锥虫)的基因组变异;2)表征不同GFF种群中锥虫耐药候选基因的表达和遗传变异;3)发现基因-环境关联和气候变化对乌干达GFF的影响;4)了解GFF种群分化的遗传和微生物群贡献;5)评估GFF扩散对媒介控制减少锥虫病负担的有效性和成本效益的影响。我们的研究将产生1)宿主-寄生虫相互作用的基本信息,这些信息将预测疾病合并的潜在风险及其流行病学后果,2)基于遗传和环境数据的GFF适宜性图,以更好地规划和操作媒介控制活动,3)寄生虫抗性的候选基因,可用于下游基因控制方法的环境适应,以及4)HAT最有效和最具成本效益的控制方法的预测。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Serap AKSOY其他文献

Serap AKSOY的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Serap AKSOY', 18)}}的其他基金

Support for Vector Biology Training for Sustainable Control of Vector Borne diseases in East Africa
支持媒介生物学培训以可持续控制东非媒介传播疾病
  • 批准号:
    10675897
  • 财政年份:
    2023
  • 资助金额:
    $ 69.4万
  • 项目类别:
Trypanosome Transmission Biology in Tsetse
采采蝇中的锥虫传播生物学
  • 批准号:
    10542426
  • 财政年份:
    2021
  • 资助金额:
    $ 69.4万
  • 项目类别:
Trypanosome Transmission Biology in Tsetse
采采蝇中的锥虫传播生物学
  • 批准号:
    10365155
  • 财政年份:
    2021
  • 资助金额:
    $ 69.4万
  • 项目类别:
Spiroplasma effects on Tsetse Flies
螺原体对采采蝇的影响
  • 批准号:
    10435557
  • 财政年份:
    2021
  • 资助金额:
    $ 69.4万
  • 项目类别:
Spiroplasma effects on Tsetse Flies
螺原体对采采蝇的影响
  • 批准号:
    10287933
  • 财政年份:
    2021
  • 资助金额:
    $ 69.4万
  • 项目类别:
Molecular Aspects of Tsetse and Trypanosome Transmission
采采蝇和锥虫传播的分子方面
  • 批准号:
    10078239
  • 财政年份:
    2019
  • 资助金额:
    $ 69.4万
  • 项目类别:
Molecular Aspects of Tsetse and Trypanosome Transmission
采采蝇和锥虫传播的分子方面
  • 批准号:
    10297859
  • 财政年份:
    2019
  • 资助金额:
    $ 69.4万
  • 项目类别:
2015 Tropical Infectious Diseases Gordon Research Conference & Seminar
2015年热带传染病戈登研究会议
  • 批准号:
    8835890
  • 财政年份:
    2015
  • 资助金额:
    $ 69.4万
  • 项目类别:
Control of Tsetse Fly Transmitted Diseases in Kenya
肯尼亚采采蝇传播疾病的控制
  • 批准号:
    8985655
  • 财政年份:
    2015
  • 资助金额:
    $ 69.4万
  • 项目类别:
Expanding the toolbox for tsetse reproductive biology
扩展采采蝇生殖生物学的工具箱
  • 批准号:
    8789330
  • 财政年份:
    2014
  • 资助金额:
    $ 69.4万
  • 项目类别:

相似海外基金

The catalytic core of the proteasome as a drug target to treat Human African Trypanosomiasis
蛋白酶体的催化核心作为治疗非洲人类锥虫病的药物靶点
  • 批准号:
    10511408
  • 财政年份:
    2022
  • 资助金额:
    $ 69.4万
  • 项目类别:
A One Health approach to investigating the ecology of East African trypanosomiasis in Malawian wildlife
调查马拉维野生动物中东非锥虫病生态学的“同一个健康”方法
  • 批准号:
    476178
  • 财政年份:
    2022
  • 资助金额:
    $ 69.4万
  • 项目类别:
    Studentship Programs
The catalytic core of the proteasome as a drug target to treat Human African Trypanosomiasis
蛋白酶体的催化核心作为治疗非洲人类锥虫病的药物靶点
  • 批准号:
    10677879
  • 财政年份:
    2022
  • 资助金额:
    $ 69.4万
  • 项目类别:
Multi-target approach to rational design of novel therapeutics for human African trypanosomiasis
多目标方法合理设计非洲人类锥虫病新疗法
  • 批准号:
    10466942
  • 财政年份:
    2021
  • 资助金额:
    $ 69.4万
  • 项目类别:
Multi-target approach to rational design of novel therapeutics for human African trypanosomiasis
多目标方法合理设计非洲人类锥虫病新疗法
  • 批准号:
    10296873
  • 财政年份:
    2021
  • 资助金额:
    $ 69.4万
  • 项目类别:
Multi-target approach to rational design of novel therapeutics for human African trypanosomiasis
多目标方法合理设计非洲人类锥虫病新疗法
  • 批准号:
    10706306
  • 财政年份:
    2021
  • 资助金额:
    $ 69.4万
  • 项目类别:
Reducing and replacing the animal cost of functional genetics in African trypanosomiasis
减少和替代非洲锥虫病功能遗传学的动物成本
  • 批准号:
    NC/W001144/1
  • 财政年份:
    2021
  • 资助金额:
    $ 69.4万
  • 项目类别:
    Research Grant
Development of new drug for African trypanosomiasis based on elucidation of the mechanism of antiprotozoal action by ribavirin.
基于利巴韦林抗原虫作用机制的阐明,开发治疗非洲锥虫病的新药。
  • 批准号:
    21K18230
  • 财政年份:
    2021
  • 资助金额:
    $ 69.4万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Pioneering)
Development of a novel control measure for African trypanosomiasis based on the blocking of lifecycle progression
基于生命周期进展阻断的非洲锥虫病新型控制措施的开发
  • 批准号:
    20K07467
  • 财政年份:
    2020
  • 资助金额:
    $ 69.4万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Drug-diagnostic co-development in Tropical Medicine, combating Human African Trypanosomiasis
热带医学药物诊断联合开发,抗击非洲人类锥虫病
  • 批准号:
    18KK0454
  • 财政年份:
    2019
  • 资助金额:
    $ 69.4万
  • 项目类别:
    Fund for the Promotion of Joint International Research (Fostering Joint International Research (A))
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了